NT-0231.F

N/A

Report date: 2022/05/19 16:14:38
NME

Base Information

Drug NameNT-0231.F
Drug Alias NameNT-0231.F
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionMyotonin-protein kinase inhibitorsRNA inhibitors
TargetsMyotonin-protein kinaseRibonucleic Acid
Therapy Area/IndicationsMyotonic Dystrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeubase Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeubase Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMyotonic Dystrophy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A